Citation

Yee AJ, Kuter DJ. Ann. Pharmacother. 2006; 40(2): 336-339.

Affiliation

Hematology/Oncology Unit, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114-2621, USA.

Copyright

(Copyright © 2006, Harvey Whitney Books)

DOI

10.1345/aph.1G494

PMID

16449547

Abstract

OBJECTIVE: To report the case of a critically ill man with heparin-induced thrombocytopenia (HIT) who received a 125 mg overdose of the direct thrombin inhibitor argatroban. CASE SUMMARY: A 74-year-old man with a history of Crohn's disease underwent takedown of an ileorectal fistula. He developed HIT postoperatively and was treated with argatroban. He became critically ill and was transferred to the intensive care unit. On postoperative day 24, he accidentally received argatroban 125 mg over 1 hour (26 microg/kg/min). Treatment with fresh frozen plasma (FFP) was effective, and there were no significant complications. The partial thromboplastin time, however, continued to be prolonged 48 hours after the overdose. DISCUSSION: Medication errors with direct thrombin inhibitors are common. However, there is no known reversal agent for this class of anticoagulants. This patient was treated with FFP and did well, with no bleeding complications. However, the clearance of argatroban was prolonged. CONCLUSIONS: This case illustrates that supratherapeutic doses of argatroban can be managed with FFP and tolerated without significant complications.

Language: en